Trial Profile
Phase II clinical trial of sequential non-randomized uncontrolled, multicenter Everolimus treatment of classic Kaposi's sarcoma or endemic [therapeutique de phase II sequentiel non randomise non controle, multicentrique de traitement par everolimus de la maladie de Kaposi classique ou endemique.]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2011
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- Acronyms Rad Kaposi
- 29 Aug 2011 New trial record